Molecular glue technology has emerged as a promising strategy for eliminating cancerous T cells. By designing specific molecular glues, researchers can selectively bind inhibitory molecules to diseased T cells, marking them for destruction and reactivating the immune system's natural cancer-fighting mechanisms.